A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Cilostazol (Primary) ; Aspirin
- Indications Thrombotic microangiopathy
- Focus Therapeutic Use
- Acronyms Challenge
- 23 Sep 2016 Planned End Date changed from 1 Feb 2016 to 1 Oct 2018.
- 23 Sep 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Aug 2018.
- 23 Sep 2016 Status changed from recruiting to active, no longer recruiting.